A breakthrough pancreatic cancer drug won approval. They still struggle to access it
STAT News · LC · trust 31/100
When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping for quick access have been stymied.
Read the original at STAT News →
Open in TruthVane →